Possibia

3121638

Last Update Posted: 2017-04-20

Recruiting has ended

All Genders

accepted

20 Years +

150 Estimated Participants

No Expanded Access

Interventional Study

Accepts healthy volunteers

Safety Study of NBP608 in Healthy Adult Volunteers

  • Indication: Protection against varicella and herpes zoster

  • Study Objectives

    • Primary: Safety and tolerability assessment after single dose administration of NBP608
    • Secondary: immunogenicity assessment after single dose administration of NBP608

This is a single-center, open label, active controlled, dose-escalation, parallel group study to assess the safety, tolerability and immunogenicity of NBP608 in healthy adult volunteers. Total of 150 healthy subjects aged 20 and over are enrolled, and each subject is administered with single dose of vaccine which is sequentially assigned to active group 1, 2 and study group 1~3 in 1:1:1:1:1 ratio(30 subjects are enrolled at each groups) .

Eligibility

Relevant conditions:

Varicella Zoster

Immunization; Infection

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov